Senior Director, Pharmaceutical Science Portfolio Strategy Lead

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

Objective:

This role serves as the single point of contact for R&D CMC Portfolio Strategy enabling activities on behalf of the CMC community within R&D, but also in collaboration with R&D & GMS GQ MPD GPLS on overseeing and driving our portfolio governance (R&D CMC governance office), portfolio insights and portfolio stakeholder management.

• R&D CMC Strategy Leader & Stakeholder Management: Accountable for oversight of the Pharm Sci Portfolio Strategy in Pharm Sci and R&D. Autonomously collaborates, mentors and champions CMC leads/teams to influence the development, alignment of plans with key stakeholders and oversee the execution of multiple, complex program strategies. Actively engaged in the broader pharma industry to understand CMC portfolio trends and insights. Proactively contributes to wider Takeda portfolio community to enhance communication of Pharm Sci portfolio dynamics, risks and opportunities.

• Head of Pharm Sci CMC Governance Office: Accountable for facilitating the Pharm Sci CMC Governance advisory board, comprised of senior-level CMC experts to advise Pharm Sci teams towards winning CMC development strategies. In collaboration with Head of Pharm Sci, R&D Therapeutic Area Units Strategy Leads, R&D Portfolio and other key stakeholders, deliver on the imperatives of the R&D CMC Strategy Review Board by ensuring program are reviewed and advised at key inflection points, teams are prepared with clear business plans, and decisions are clearly communicated and maintained.

• R&D CMC Digital & Industry-leading Portfolio: Develops and drives digital-based processes and mechanisms for real-time portfolio analytics towards enhancing portfolio prioritization, decision-making and delivering on business objectives. Lead the R&D CMC efforts for leveraging digital and AI tools to translate complex insights into actionable recommendations related to program and portfolio deliverables. Deliver competitive intelligence and industry benchmarking to assess R&D CMC's position in key areas and work with portfolio teams to optimize top-tier development cycle times to accelerate drug to patients.

Accountabilities:                                                                                                                                                                                                  

• Senior level R&D CMC portfolio strategy leader accountable for influencing and overseeing the Pharm Sci Portfolio Strategy. Able to clearly articulate deep technical CMC development plans and concepts to a wide variety of audiences across Pharm Sci, R&D and Commercial that includes various types of complicated, global CMC programs (pre-clinical to commercialized programs, diverse therapeutic areas, geographic footprints, and various technical platforms & modalities (for example, synthetic molecules, oligonucleotides, peptides, mAb and mAb fragments, complex biologics such as ADCs and combination products consisting of simple to complex device elements). 

• Autonomously collaborates, mentors and champions CMC-leads/teams to influence the development, alignment of plans with key stakeholders and oversee the execution of individual program strategies across all programs and types. As a mentor to CMC leads/teams, able to use soft skills to cultivate a strategic mind-set for program planning that aligns with business needs. Ensures well-thought through program plans are brought to R&D governance for review. Able to see trends across programs and help others learn to adapt their thinking t